Global E-Prescribing market report 2024, Forecast To 2033

The e-prescribing market has witnessed exponential growth, surging from $2.12 billion in 2023 to $2.65 billion in 2024, reflecting a noteworthy compound annual growth rate (CAGR) of 25.0%. The growth in the historic period is attributed to regulatory mandates, efforts in reducing medication errors, advancements in patient safety, improvements in prescription workflows, and increased prescriber efficiency. Foreseeing continued exponential growth in the next few years, the market size is projected to reach $6.47 billion in 2028, sustained by a consistent CAGR of 25.0%. Factors contributing to this growth include the expansion of the telemedicine sector, the growing adoption of personalized medicine, the implementation of prescription drug monitoring programs, the evolution of medication therapy management, and the global initiatives supporting e-prescribing. Major trends in the forecast period encompass initiatives in interoperability and health information exchange, advancements in medication reconciliation, the implementation of electronic prior authorization, the development of medication adherence tools, the incorporation of eRx for controlled substances, and the integration of AI-driven alerts and decision support.